Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0F7NL
|
|||
| Drug Name |
PMID28447479-Compound-20
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
BIOGEN MA INC
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H19F6N3O4
|
|||
| Canonical SMILES |
CCOC(=O)C1=NN2CCCN(CC2=C1)C(=O)OCC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F
|
|||
| InChI |
1S/C20H19F6N3O4/c1-2-32-17(30)16-9-15-10-28(4-3-5-29(15)27-16)18(31)33-11-12-6-13(19(21,22)23)8-14(7-12)20(24,25)26/h6-9H,2-5,10-11H2,1H3
|
|||
| InChIKey |
UVKJSSLAVQPIDP-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Extracellular lysophospholipase D (E-NPP2) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Extracellular lysophospholipase D (E-NPP2) | Target's Patent Info | [1] | |
| KEGG Pathway | Ether lipid metabolism | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Autotaxin inhibitors: a patent review (2012-2016).Expert Opin Ther Pat. 2017 Jul;27(7):815-829. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.